AU2139388A - Glycosaminoglycane for the treatment of diabetic microangiopathy - Google Patents
Glycosaminoglycane for the treatment of diabetic microangiopathyInfo
- Publication number
- AU2139388A AU2139388A AU21393/88A AU2139388A AU2139388A AU 2139388 A AU2139388 A AU 2139388A AU 21393/88 A AU21393/88 A AU 21393/88A AU 2139388 A AU2139388 A AU 2139388A AU 2139388 A AU2139388 A AU 2139388A
- Authority
- AU
- Australia
- Prior art keywords
- diabetic microangiopathy
- glycosaminoglycane
- treatment
- prophylaxy
- glycosaminoglycanes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Abstract
It has been discovered that glycosaminoglycanes such as chondroitin sulphate are highly effective as therapeutic and prophylactic agents against diabetic microangiopathy (retinopathy, nephropathy and other manifestations related to capillary pathologies). Glycosaminoglycanes may be used as oral, parenteral or topic preparations for the therapy and prophylaxy of diabetic microangiopathy. Because of its effectiveness when orally administered and of its remarkable compatibility, the oral administration of chondroitin sulphate is particularly advantageous, since this compound is specially suitable for the long term therapy and prophylaxy of diabetic microangiopathy.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2442/88 | 1988-06-27 | ||
CH244288 | 1988-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2139388A true AU2139388A (en) | 1990-01-23 |
Family
ID=4233917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU21393/88A Abandoned AU2139388A (en) | 1988-06-27 | 1988-08-18 | Glycosaminoglycane for the treatment of diabetic microangiopathy |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0380501B1 (en) |
JP (1) | JPH03500168A (en) |
AT (1) | ATE81462T1 (en) |
AU (1) | AU2139388A (en) |
DE (1) | DE3875349D1 (en) |
WO (1) | WO1990000058A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1245907B (en) * | 1991-05-17 | 1994-10-25 | Alfa Wassermann Spa | USE OF GLYCOSAMINOGLICANS IN THE TREATMENT OF DIABETIC NEPHROPATHY AND DIABETIC NEUROPATHY. |
US5888984A (en) * | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
IT1270095B (en) * | 1994-09-28 | 1997-04-28 | Ibsa Inst Biochimique Sa | THERAPEUTIC COMPOSITIONS OF CHONDROITIN SULPHATE IN THE FORM OF ORAL ADMINISTRABLE GEL |
WO1998033494A1 (en) * | 1997-02-04 | 1998-08-06 | Kosbab John V | Compositions and methods for prevention and treatment of vascular degenerative diseases |
AU9160498A (en) * | 1997-07-28 | 1999-02-16 | Rijksuniversiteit Leiden | Use of sulfated glycosaminoglycans for treating of retinopathy |
DE19747195A1 (en) * | 1997-10-24 | 1999-04-29 | Knoll Ag | Compositions for treating diabetic retinopathy |
WO2000044367A2 (en) | 1999-02-01 | 2000-08-03 | Dermal Research Laboratories, Inc. | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
JP4554910B2 (en) * | 2002-11-01 | 2010-09-29 | 生化学工業株式会社 | Hypoglycemic agent |
JP2009234916A (en) * | 2006-07-24 | 2009-10-15 | Stelic Institute Of Regenerative Medicine | Insulin resistance reducer based on chondroitin sulfate proteoglycan accumulation regulation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2544136B2 (en) * | 1986-05-23 | 1996-10-16 | 第一製薬株式会社 | Angiogenesis inhibitor and antitumor agent containing sulfated polysaccharide DS4152 |
US5021404A (en) * | 1988-04-20 | 1991-06-04 | The Children's Medical Center Corporation | Angiostatic collagen modulators |
JP2667441B2 (en) * | 1988-05-18 | 1997-10-27 | 生化学工業株式会社 | Vascular endothelial cell growth inhibitor |
-
1988
- 1988-08-18 AU AU21393/88A patent/AU2139388A/en not_active Abandoned
- 1988-08-18 DE DE8888907137T patent/DE3875349D1/en not_active Expired - Fee Related
- 1988-08-18 WO PCT/CH1988/000141 patent/WO1990000058A1/en active IP Right Grant
- 1988-08-18 AT AT88907137T patent/ATE81462T1/en not_active IP Right Cessation
- 1988-08-18 EP EP88907137A patent/EP0380501B1/en not_active Expired - Lifetime
- 1988-08-18 JP JP63506541A patent/JPH03500168A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1990000058A1 (en) | 1990-01-11 |
EP0380501B1 (en) | 1992-10-14 |
JPH03500168A (en) | 1991-01-17 |
EP0380501A1 (en) | 1990-08-08 |
ATE81462T1 (en) | 1992-10-15 |
DE3875349D1 (en) | 1992-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0217206A3 (en) | Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes | |
KR870005637A (en) | Drug depot | |
IT1252868B (en) | ANTI-PHALALGIC PHARMACEUTICAL COMPOSITION FOR ENDONASAL ADMINISTRATION, PROCEDURE TO PREPARE IT AND ITS THERAPEUTIC USE | |
MY132705A (en) | Novel compounds with analgesic effect | |
AU6444786A (en) | The use of 2-amino-3-benzoylbenzeneacetic acids and derivatives in pharmaceutical preparations | |
MY119403A (en) | Novel compounds with analgesic effect. | |
MY114389A (en) | Aqueous risperidone formulations | |
IE893840L (en) | Use of acetyl d-carnitines for treating glaucoma | |
IL96415A0 (en) | Oral composition for the treatment of inflammatory bowel diseases | |
ES2140565T3 (en) | NEW DERIVATIVES OF PIRAZINE-CARBOXAMIDE, ITS PREPARATION AND ITS USE IN MEDICINES. | |
ATE282418T1 (en) | ORAL ADMINISTRATION OF EFFECTIVE AMOUNTS OF HYALURONIC ACID | |
AU1578688A (en) | Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines | |
AU3951389A (en) | The use of alpha-amino boronicacid derivatives for the prophylaxis and treatment of virus diseases | |
AU2139388A (en) | Glycosaminoglycane for the treatment of diabetic microangiopathy | |
EP0879597A4 (en) | Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same | |
AU2749288A (en) | Use of polysulfated heparins | |
AU2861389A (en) | Disubstituted pyridines | |
PH27446A (en) | Compound with gastric acid inhibitory effect | |
AU1956092A (en) | Pharmaceutical agent for treatment of withdrawal symptoms | |
CA2095352A1 (en) | Compositions containing psyllium | |
YU13599A (en) | Use of pharmaceutical composition for preparation of medicament in a gel form | |
AU3709289A (en) | Strontium salt | |
AU4040195A (en) | Topical composition containing penciclovir | |
ES2170377T3 (en) | COMPOSITION CONTAINING QUITOSANA. | |
IT1243368B (en) | Use of bendazac and of its pharmaceutically acceptable salts |